Nuevo Usuario

Recordar Contraseña

Revista de Medicina de Laboratorio 00044 / http://dx.doi.org/10.20960/revmedlab.00044

Resumen| PDF

Revisiones - Metaanálisis

Fiebre hemorrágica de Crimea-Congo, otra enfermedad emergente

Ángel San Miguel Hernández, José María Eiros Bouza

Prepublicado: 2020-12-29

Publicado: 2020-12-29

VOLUMEN 1, NÚM. 3, septiembre-diciembre (2020), PAG. 120-126

Logo Descargas Número de descargas: 6435 Logo Visitas Número de visitas: 4290 Citas Citas: 0

Compártelo:

Recientemente, apareció un nuevo caso mortal de fiebre hemorrágica de Crimea-Congo en Salamanca, un varón de 69 años y que había presentado una sintomatología inespecífica. Su estado se fue agravando y se descubrió una lesión negruzca en una pierna, justo donde en días previos había sufrido una picadura de garrapata. La fiebre hemorrágica de Crimea-Congo es una enfermedad febril leve que puede progresar a un cuadro hemorrágico grave y a menudo mortal. Se la considera una enfermedad emergente en países de Europa oriental y una de las enfermedades trasmitidas por garrapatas con mayor extensión a nivel mundial.

Palabras Clave: Virus de la fiebre hemorrágica de Crimea-Congo. Garrapatas. Mortalidad.

Descargar PDF

Bibliografía
Artículos Relacionados

Sanchez-Seco Fariñas MP, Muñoz García de Paredes P, Eiros Bouza JM. Viriasis emergentes. Tratado SEIMC de Enfermedades Infecciosas y Microbiología Clínica. Ausina Ruiz V, Moreno Gillén, dirs. Editorial Médica panamericana. Madrid, 2006: 1007-13.

Rasmussen AL, Katxen MG. Genomic signatures of emerging viruses. A new era of systems epidemiology. Cell Host Microbe 2016; 19:611-8
DOI: 10.1016/j.chom.2016.04.016

De Wit, van Doremalen N, Falzarano D, Munster VJ. SARS and MERS: recent insights into emerging coronaviruses. Nat Rev Microbiol 2016; 19;523-34
DOI: 10.1038/nrmicro.2016.81

Biek R, Leal LA. The landscape genetics of infectious disease emergence and spread. Mol Ecol 2010: 19:3515-31
DOI: 10.1111/j.1365-294X.2010.04679.x

Prevención de las Enfermedades transmitidas por garrapatas Castilla y León. Recuperado el 29 de agosto de 2020 de: http://www.saludcastillayleon.es/ciudadanos/en/sanidadambiental/enfermedades-transmitidas- garrapatas

Informe de situación y evaluación del riesgo de transmisión del virus de fiebre hemorrágica de crimea-congo (FHCC) en España. 2019.Recuperado el 29 de agosto de 2020 de: https://www.mscbs.gob.es/profesionales/saludPublica/ccayes/analisisituacion/doc/ER_FHCC.pdf.

Zimmermann R, Hattendorf J, Blum J, Nüesch R, Hatz C. Risk perception of travelers to tropical and subtropical countries visiting a swiss travel health canter. J Travel Med 2013; 20:3-10.
DOI: 10.1111/j.1708-8305.2012.00671.x

Palomar AM, Portillo A, Mazuelas D, Roncero L, Arriaga J, Crespo A, et al. Molecular analysis of Crimean-Congo hemorrhagic fever virus and Rickettsia in Hyalomma marginatum ticks removed from patients (Spain) and birds (Spain and Morocco), 2009-2015. Ticks Tick Borne Dis 2016; 7: 983-7
DOI: 10.1016/j.ttbdis.2016.05.004

Eiros Bouza JM. Función de los laboratorios centrales de referencia en el diagnóstico Serológico de las enfermedades infecciosas. Enferm Infecc Microbiol Clin 2005; Monogr 4: 78- 81.

Monsalve-Arteaga L, Alonso-Sardón M, Muñoz Bellido JL, Vicente Santiago MB, Vieira Lista M, López Abán J, et al. Seroprevalence of Crimean-Congo hemorrhagic fever in humans in the World Health Organization European region: A systematic review. PLoS Negl Trop Dis. 2020 Mar; 14(3): e0008094. Published online 2020 Mar 2.
DOI: 10.1371/journal.pntd.0008094

Monsalve Arteaga L, Muñoz Bellido JL, Vieira Lista MC, Vicente Santiago MB, Fernández Soto P; Bas I, et al. Crimean-Congo haemorrhagic fever (CCHF) virus-specific antibody detection in blood donors, Castile-León, Spain, summer 2017 and 2018. Euro Surveill. 2020 Mar 12; 25(10): 1900507.
DOI: 10.2807/1560-7917.ES.2020.25.10.1900507

Bartolini B, Gruber CEM, Koopmans M, Avšič T, Bino S, Christova I, et al. Laboratory management of Crimean-Congo haemorrhagic fever virus infections: perspectives from two European networks. Euro Surveill. 2019 Jan 31; 24(5): 1800093.
DOI: 10.2807/1560-7917.ES.2019.24.5.1800093

Blair PW, Kuhn JH, Pecor DB, Apanaskevich DA, Kortepeter MG, Cardile AP, et al. An Emerging Biothreat: Crimean-Congo Hemorrhagic Fever Virus in Southern and Western Asia. Am J Trop Med Hyg. 2019 Jan; 100(1): 16–23.
DOI: 10.4269/ajtmh.18-0553

Mendoza EJ, Warner B, Safronetz D, Ranadheera C. Crimean–Congo haemorrhagic fever virus: Past, present and future insights for animal modelling and medical countermeasures. Zoonoses Public Health. 2018 Aug; 65(5): 465–480.
DOI: 10.1111/zph.12469

Tipih T, Jane Burt F. Crimean–Congo Hemorrhagic Fever Virus: Advances in Vaccine Development. Biores Open Access. 2020; 9(1): 137–150.
DOI: 10.1089/biores.2019.0057

Hawman DW, Feldmann H. Recent advances in understanding Crimean–Congo hemorrhagic fever virus. Version 1. F1000Res. 2018; 7: F1000 Faculty Rev-1715. Published online 2018 Oct 29.
DOI: 10.12688/f1000research.16189.1

Spengler JR, Bergeron E, Rollin PE. Seroepidemiological Studies of Crimean-Congo Hemorrhagic Fever Virus in Domestic and Wild Animals. PLoS Negl Trop Dis. 2016 Jan; 10(1): e0004210.
DOI: 10.1371/journal.pntd.0004210

Seif S. Al-Abri, Idris Al Abaidani, Mehdi Fazlalipour, Ehsan Mostafavi, Hakan Leblebicioglu, Natalia Pshenichnaya, et al. Current status of Crimean-Congo haemorrhagic fever in the World Health Organization Eastern Mediterranean Region: issues, challenges, and future directions. Int J Infect Dis. 2017 May; 58: 82–89.
DOI: 10.1016/j.ijid.2017.02.018

Ergönül O, Keske S, Melis Gökçe Çeldir, İlayda Arjen Kara, Natalia Pshenichnaya, Gulzhan Abuova, et al. Systematic Review and Meta-analysis of Postexposure Prophylaxis for Crimean-Congo Hemorrhagic Fever Virus among Healthcare Workers. Emerg Infect Dis. 2018 Sep; 24(9): 1642–1648.
DOI: 10.3201/eid2409.171709

Grech-Angelini S, Lancelot R, Ferraris O, Peyrefitte CH, Vachiery N, Pédarrieu A, et al. Crimean-Congo Hemorrhagic Fever Virus Antibodies among Livestock on Corsica, France, 2014–2016. Emerg Infect Dis. 2020 May; 26(5): 1041–1044.
DOI: 10.3201/10.3201/eid2605.191465

Messina JP, Pigott DM, Golding N, Duda KA, Brownstein JS, Weiss DJ, Gibson H, et al. The global distribution of Crimean-Congo hemorrhagic fever. Trans R Soc Trop Med Hyg. 2015 Aug; 109(8): 503–513.
DOI: 10.1093/trstmh/trv050

Dowall SD, Carroll MW, Hewson R. Development of vaccines against Crimean-Congo haemorrhagic fever virus. Vaccine. 2017; 20; 35(44): 6015–6023.
DOI: 10.1016/j.vaccine.2017.05.031

Spengler JR, Éric Bergeron, Christina F Spiropoulou. Crimean-Congo hemorrhagic fever and expansion from endemic regions. Curr Opin Virol. Author manuscript; available in PMC 2019 May 2. Published in final edited form as: Curr Opin Virol. 2019; 34: 70–78. Published online 2019 Jan 16.
DOI: 10.1016/j.coviro.2018.12.002

Mazzola LT, Cassandra Kelly-Cirino. Diagnostic tests for Crimean-Congo haemorrhagic fever: a widespread tickborne disease. BMJ Glob Health. 2019; 4(Suppl 2): e001114. Published online 2019 Feb 20.
DOI: 10.1136/bmjgh-2018-001114

Negredo A, Habela MA, Ramírez de Arellano E, Diez F, Lasala F, López P, et al. Survey of Crimean-Congo Hemorrhagic Fever Enzootic Focus, Spain, 2011–2015. Emerg Infect Dis. 2019 Jun; 25(6): 1177–1184.
DOI: 10.3201/eid2506.180877

Papa A, Mirazimi A, Köksal I, Estrada-Pena A, Feldmann H. Recent advances in research on Crimean-Congo hemorrhagic fever. J Clin Virol. J Clin Virol. 2015 Mar; 64: 137–143. Published online 2014 Oct 22.
DOI: 10.1016/j.jcv.2014.08.029

Garrison AR, Smith DR, Golden JW. Animal Models for Crimean-Congo Hemorrhagic Fever Human Disease. Viruses. 2019 Jul; 11(7): 590.
DOI: 10.3390/v11070590

Emmerich P, Mika A, von Possel R, Rackow A, Liu Y, Schmitz H, et al. Sensitive and specific detection of Crimean-Congo Hemorrhagic Fever Virus (CCHFV)—Specific IgM and IgG antibodies in human sera using recombinant CCHFV nucleoprotein as antigen in μ- capture and IgG immune complex (IC) ELISA tests. PLoS Negl Trop Dis. 2018 Mar; 12(3): e0006366. Published online 2018 Mar 26.
DOI: 10.1371/journal.pntd.0006366

Hasan Tahsin Gozdas. Evaluation of Crimean-Congo hemorrhagic fever suspected cases admitted to a secondary care hospital in Kastamonu, Turkey between 2014–2017. Afr Health Sci. 2019 Mar; 19(1): 1433–1440.
DOI: 10.4314/ahs.v19i1.16

Spengler JR, Estrada-Peña A, Garrison AR, Schmaljohn C, Spiropoulou CF, Bergeron E, et al. A chronological review of experimental infection studies of the role of wild animals and livestock in the maintenance and transmission of Crimean-Congo hemorrhagic fever virus. Antiviral Res 2017 Nov 1. Published in final edited form as: Antiviral Res. 2016 Nov; 135: 31. Published online 2016 Oct 3.
DOI: 10.1016/j.antiviral.2016.09.013

Al-Abri SS, Roger Hewson, Hanan Al-Kindi, Idris Al-Abaidani, Amina Al-Jardani, Amal Al- Maani, Samira Almahrouqi, Barry Atkinson, Adil Al-Wahaibi, Bader Al-Rawahi, Shyam Bawikar, Nicholas J. Beeching. Clinical and molecular epidemiology of Crimean-Congo hemorrhagic fever in Oman. PLoS Negl Trop Dis. 2019 Apr; 13(4): e0007100. Published online 2019 Apr 25.
DOI: 10.1371/journal.pntd.0007100

Papa A, Tsergouli K, Tsioka K, Mirazimi A. Crimean-Congo Hemorrhagic Fever: Tick-Host- Virus Interactions. Front Cell Infect Microbiol. 2017; 7: 213. Published online 2017 May 26.
DOI: 10.3389/fcimb.2017.00213

Maryam Keshtkar-Jahromi, Mohammad M. Sajadi, Hossein Ansari, Masoud Mardani, Kourosh Holakouie Naieni. Crimean-Congo hemorrhagic fever in Iran. Antiviral Res. Author manuscript; available in PMC 2014 Dec 9. Published in final edited form as: Antiviral Res. 2013 Oct; 100(1): 20–28.
DOI: 10.1016/j.antiviral.2013.07.007

Spengler JR, Dennis A. Bente, Mike Bray, Felicity Burt, Roger Hewson, Gülay Korukluoglu, Ali Mirazimi, Friedemann Weber, Papa A. Second International Conference on Crimean-Congo Hemorrhagic Fever. Antiviral Res. Author manuscript; available in PMC 2019 May 2. Published in final edited form as: Antiviral Res. 2018 Feb; 150: 137–147. Published online 2017 Dec 2.
DOI: 10.1016/j.antiviral.2017.11.019

Head JR, Bumburidi Y, Gulfaira Mirzabekova, Kumysbek Rakhimov, Marat Dzhumankulov, Stephanie J. Salyer, et al. Risk Factors for and Seroprevalence of Tickborne Zoonotic Diseases among Livestock Owners, Kazakhstan. Emerg Infect Dis. 2020 Jan; 26(1): 70–80.
DOI: 10.3201/eid2601.190220

Jeffrey W. Koehler, Korey L. Delp, Adrienne T. Hall, Scott P. Olschner, Brian J. Kearney, Aura R. Garrison, et al. Sequence Optimized Real-Time Reverse Transcription Polymerase Chain Reaction Assay for Detection of Crimean-Congo Hemorrhagic Fever Virus. Am J Trop Med Hyg. 2018 Jan; 98(1): 211–215. Published online 2017 Nov 20.
DOI: 10.4269/ajtmh.17-0165

Dominique Goedhals, Janusz T. Paweska, Felicity J. Burt. Long-lived CD8+ T cell responses following Crimean-Congo haemorrhagic fever virus infection. PLoS Negl Trop Dis. 2017 Dec; 11(12): e0006149. Published online 2017 Dec 19.
DOI: 10.1371/journal.pntd.0006149

Shirin Barzanjeh atri, Ranjbar F, Sahebihag Hh, Jafarabadi MA, Vahedi P, Balafar M, Keyhaniazar E. 150: using evidence-based education: a necessary approach in the prevention of emerging diseases Crimean Congo. BMJ Open. 2017; 7 (Suppl 1): bmjopen-2016- 015415.150. Published online 2017 Feb 8.
DOI: 10.1136/bmjopen-2016-015415.141